1. Regan isoenzyme and human chorionic gonadotrophin in ovarian cancer;Fishman, W.H.; Inglis, N.R.; Vaitukaitis, J.; Stolbach, L.L.;National Cancer Institute Monograph,1975
2. Human placental alkaline phosphatase in benign and malignant ovarian neoplasia;Nouwen, E.J.; Pollet, D.E.; Schelstraete, J.B.; Eerdekens, M.W.; Hansch, C.; Van de Voorde, A.;CancerRes,1985
3. Placental alkaline phosphatase as a tumour marker for seminoma;Lange, P.H.; Millan, J.L.; Stigbrand, T.; Vessella, R.L.; Ruoslahti, E.; Fishman, W.H.;Cancer Res,1982
4. Detection of placental-type alkaline phosphatase in ovarian cancer;McDicken, I.W.; McLaughlin, P.J.; Tromans, P.M.; Luesley, D.M.; Johnson, P.M.;Br J Cancer,1985
5. Placental alkaline phosphatase as a tumour marker in seminoma using the H17E2 monoclonal antibody assay;Horwich, A.; Tucker, D.F.; Peckham, M.J.;Br JT Cancer,1985